RCKTLawsuits•prnewswire•
RCKT INVESTOR NOTICE: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Sentiment:Negative (-80)
Summary
SAN DIEGO, June 18, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, both dates inclusive (the Class Period), have until...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 18, 2025 by prnewswire